Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
Kakolyris S, Papadakis E, Tsiafaki X, Kalofonos C, Rapti A, Toubis M, Bania E, Kouroussis C, Chainis K, Androulakis N, Agelaki S, Sarra E, Vardakis N, Georgoulias V; Greek Cooperative Group for Lung Cancer.
Kakolyris S, et al. Among authors: sarra e.
Lung Cancer. 2001 May;32(2):179-87. doi: 10.1016/s0169-5002(00)00212-9.
Lung Cancer. 2001.
PMID: 11325489
Clinical Trial.